The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.
about
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapiesThe Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at HandExpression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.Fibroblast growth factor 2 causes G2/M cell cycle arrest in ras-driven tumor cells through a Src-dependent pathway.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.The influence of Cox-2 and bioactive lipids on hematological cancers.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Effects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats.What role for angiogenesis in childhood acute lymphoblastic leukaemia?LTBP-2 Has a Single High-Affinity Binding Site for FGF-2 and Blocks FGF-2-Induced Cell Proliferation.Toxicarioside A inhibits SGC-7901 proliferation, migration and invasion via NF-κB/bFGF signaling.Gene therapy for radioprotection.Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lungTargeting cyclooxygenase-2 in hematological malignancies: rationale and promiseProtein arginine methyltransferase 5 is essential for growth of lung cancer cells.Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerThe role of fibroblast growth factors in tumor growthBasic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid LeukemiaIL-1beta differently involved in IL-8 and FGF-2 release in crystalline silica-treated lung cell co-cultures.Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma.FGFR1 expression and gene copy numbers in human lung cancer.An emerging case for membrane pore formation as a common mechanism for the unconventional secretion of FGF2 and IL-1β.An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression.The impact of statins on FGF-2-stimulated human umbilical vein endothelial cells.Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.
P2860
Q28079232-9CA1311C-3EC2-434F-B79D-1755CFE2D102Q28085435-2CE9728B-CE42-4E0D-BCDC-25D7CD9A578BQ30009050-381B5566-9E6F-41E0-8910-6068EE434406Q31133056-CDCA6749-0447-484B-9208-E36CB9FFDC9BQ33572306-5730EE26-43A9-4F5D-A25A-B90B938F77E5Q33688673-067CF82D-B356-46D5-9955-94460DED0F1EQ34273411-18FD8CBA-11DC-4049-A8DE-CC833844364EQ34585197-BC167E95-FD65-4D97-8F47-E79ABBF9BD54Q35550914-73234E6F-769E-4CF0-AEB5-D7ED91C5A230Q35742847-30E3D0D5-BAE2-4580-A6AD-7841FFAE6623Q35886637-1C14A846-55DE-4AD5-98D4-830347D9B2A0Q36170038-1D39C3D7-B8AE-4DB6-BED3-87682BE59D54Q36262168-30C7A1E0-1C7D-4E33-9651-F52900365834Q37239890-CC0037CA-8939-4577-843F-476A4C023DA9Q37398814-0C0505D3-9B6E-444F-BA2D-7ACB37E35763Q37413167-457CDAF9-B7E9-4327-969D-6413314D04EEQ37512303-53E0B608-7226-4BC7-911B-C15062EF3BEAQ38904172-E1986A46-6843-4186-9FCA-D83AF0B33F05Q39521060-279F5E27-2244-48D8-8D1D-3637C9050B04Q41089780-D81A0C1F-D6BC-42E8-8E7C-DF82AC89A189Q41594024-6EC20597-311C-455D-87F1-0CE10322E38FQ41849671-A91BFF6D-1E9F-4E33-B1C6-40EDD4FD5951Q42658363-B5F2BBAA-A67D-456C-9EC9-29EC2B2ED416Q47682862-C4F2C721-3049-4F07-9600-05874F3DDE86Q47857405-A3BDEC11-E4A3-4FD0-A174-9CE8E933A81BQ50228598-3437DD46-8E3E-4C73-9907-AAB8FCC5BED9Q51062853-D8D01E88-5BBD-4371-8158-498A0126F9A3Q52646637-E406CAB1-272E-4E9D-A8CF-2BEB3E266393Q53098448-5BECF91D-481E-457C-8CF1-2EBB0A8EE295
P2860
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The discovery of basic fibrobl ...... n haematological malignancies.
@ast
The discovery of basic fibrobl ...... n haematological malignancies.
@en
The discovery of basic fibrobl ...... n haematological malignancies.
@nl
type
label
The discovery of basic fibrobl ...... n haematological malignancies.
@ast
The discovery of basic fibrobl ...... n haematological malignancies.
@en
The discovery of basic fibrobl ...... n haematological malignancies.
@nl
prefLabel
The discovery of basic fibrobl ...... n haematological malignancies.
@ast
The discovery of basic fibrobl ...... n haematological malignancies.
@en
The discovery of basic fibrobl ...... n haematological malignancies.
@nl
P1476
The discovery of basic fibrobl ...... in haematological malignancies
@en
P2093
Angelo Vacca
Domenico Ribatti
P304
P356
10.1016/J.CYTOGFR.2007.04.011
P577
2007-05-29T00:00:00Z